Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding

Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA). LPA is a bioactive phospholipid that regulates diverse biological processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of G protein-c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 2015-12, Vol.88 (6), p.982-992
Hauptverfasser: Stein, Adam J, Bain, Gretchen, Prodanovich, Pat, Santini, Angelina M, Darlington, Janice, Stelzer, Nina M P, Sidhu, Ranjinder S, Schaub, Jeffrey, Goulet, Lance, Lonergan, Dave, Calderon, Imelda, Evans, Jilly F, Hutchinson, John H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 992
container_issue 6
container_start_page 982
container_title Molecular pharmacology
container_volume 88
creator Stein, Adam J
Bain, Gretchen
Prodanovich, Pat
Santini, Angelina M
Darlington, Janice
Stelzer, Nina M P
Sidhu, Ranjinder S
Schaub, Jeffrey
Goulet, Lance
Lonergan, Dave
Calderon, Imelda
Evans, Jilly F
Hutchinson, John H
description Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA). LPA is a bioactive phospholipid that regulates diverse biological processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of G protein-coupled receptors. The ATX-LPA pathway has been implicated in many pathologic conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain. Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases. Mouse and rat ATX have been crystallized previously with LPA or small-molecule inhibitors bound. Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors. We demonstrate that the mechanism of inhibition of each compound reflects its unique interactions with human ATX. Our studies may provide a basis for the rational design of novel ATX inhibitors.
doi_str_mv 10.1124/mol.115.100404
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_osti_scitechconnect_1498378</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1728676474</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-f716252a367af7d82890b86951c76db8621f22e84fd0df9d076a39dd8e76f9553</originalsourceid><addsrcrecordid>eNo9kUlvFDEUhC1ERIbAlSOyOHHpwc_dXvqYTMgiBSUSIHGzPF4YR9324EUh_56OJuH06vBVqfQKoQ9A1gB0-DKnaRFsDYQMZHiFVsAodAQAXqMVIZR3cmS_jtHbUu4JgYFJ8gYdU94LAElX6P57zc3UlvWEz3QJBfuU8XXchW2oIUWcPL5qs474tNVU9d8Q8fYRX6SW8V2qLla8SfM-tWgLfgh1h89DqSGair8l68qT_yxEG-Lvd-jI66m498_3BP28-Ppjc9Xd3F5eb05vOtNzWjsvgFNGdc-F9sJKKkeylXxkYAS3i6LgKXVy8JZYP1oiuO5Ha6UT3I-M9Sfo0yE3LUVUMaE6szMpRmeqgmGUvZAL9PkA7XP601ypag7FuGnS0aVWFAgqueCDGBZ0fUBNTqVk59U-h1nnRwVEPY2glhEWwdRhhMXw8Tm7bWdn_-MvX-__AcIvgjY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1728676474</pqid></control><display><type>article</type><title>Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Stein, Adam J ; Bain, Gretchen ; Prodanovich, Pat ; Santini, Angelina M ; Darlington, Janice ; Stelzer, Nina M P ; Sidhu, Ranjinder S ; Schaub, Jeffrey ; Goulet, Lance ; Lonergan, Dave ; Calderon, Imelda ; Evans, Jilly F ; Hutchinson, John H</creator><creatorcontrib>Stein, Adam J ; Bain, Gretchen ; Prodanovich, Pat ; Santini, Angelina M ; Darlington, Janice ; Stelzer, Nina M P ; Sidhu, Ranjinder S ; Schaub, Jeffrey ; Goulet, Lance ; Lonergan, Dave ; Calderon, Imelda ; Evans, Jilly F ; Hutchinson, John H ; Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><description>Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA). LPA is a bioactive phospholipid that regulates diverse biological processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of G protein-coupled receptors. The ATX-LPA pathway has been implicated in many pathologic conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain. Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases. Mouse and rat ATX have been crystallized previously with LPA or small-molecule inhibitors bound. Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors. We demonstrate that the mechanism of inhibition of each compound reflects its unique interactions with human ATX. Our studies may provide a basis for the rational design of novel ATX inhibitors.</description><identifier>ISSN: 0026-895X</identifier><identifier>ISSN: 1521-0111</identifier><identifier>EISSN: 1521-0111</identifier><identifier>DOI: 10.1124/mol.115.100404</identifier><identifier>PMID: 26371182</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Cell Line, Tumor ; Crystallization ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - metabolism ; HEK293 Cells ; Humans ; Mice ; Phosphoric Diester Hydrolases - chemistry ; Phosphoric Diester Hydrolases - metabolism ; Protein Binding - physiology ; Protein Structure, Secondary ; Protein Structure, Tertiary ; Structure-Activity Relationship</subject><ispartof>Molecular pharmacology, 2015-12, Vol.88 (6), p.982-992</ispartof><rights>Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-f716252a367af7d82890b86951c76db8621f22e84fd0df9d076a39dd8e76f9553</citedby><cites>FETCH-LOGICAL-c362t-f716252a367af7d82890b86951c76db8621f22e84fd0df9d076a39dd8e76f9553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,782,786,887,27933,27934</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26371182$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/1498378$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Stein, Adam J</creatorcontrib><creatorcontrib>Bain, Gretchen</creatorcontrib><creatorcontrib>Prodanovich, Pat</creatorcontrib><creatorcontrib>Santini, Angelina M</creatorcontrib><creatorcontrib>Darlington, Janice</creatorcontrib><creatorcontrib>Stelzer, Nina M P</creatorcontrib><creatorcontrib>Sidhu, Ranjinder S</creatorcontrib><creatorcontrib>Schaub, Jeffrey</creatorcontrib><creatorcontrib>Goulet, Lance</creatorcontrib><creatorcontrib>Lonergan, Dave</creatorcontrib><creatorcontrib>Calderon, Imelda</creatorcontrib><creatorcontrib>Evans, Jilly F</creatorcontrib><creatorcontrib>Hutchinson, John H</creatorcontrib><creatorcontrib>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><title>Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA). LPA is a bioactive phospholipid that regulates diverse biological processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of G protein-coupled receptors. The ATX-LPA pathway has been implicated in many pathologic conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain. Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases. Mouse and rat ATX have been crystallized previously with LPA or small-molecule inhibitors bound. Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors. We demonstrate that the mechanism of inhibition of each compound reflects its unique interactions with human ATX. Our studies may provide a basis for the rational design of novel ATX inhibitors.</description><subject>Animals</subject><subject>Cell Line, Tumor</subject><subject>Crystallization</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - metabolism</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>Mice</subject><subject>Phosphoric Diester Hydrolases - chemistry</subject><subject>Phosphoric Diester Hydrolases - metabolism</subject><subject>Protein Binding - physiology</subject><subject>Protein Structure, Secondary</subject><subject>Protein Structure, Tertiary</subject><subject>Structure-Activity Relationship</subject><issn>0026-895X</issn><issn>1521-0111</issn><issn>1521-0111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kUlvFDEUhC1ERIbAlSOyOHHpwc_dXvqYTMgiBSUSIHGzPF4YR9324EUh_56OJuH06vBVqfQKoQ9A1gB0-DKnaRFsDYQMZHiFVsAodAQAXqMVIZR3cmS_jtHbUu4JgYFJ8gYdU94LAElX6P57zc3UlvWEz3QJBfuU8XXchW2oIUWcPL5qs474tNVU9d8Q8fYRX6SW8V2qLla8SfM-tWgLfgh1h89DqSGair8l68qT_yxEG-Lvd-jI66m498_3BP28-Ppjc9Xd3F5eb05vOtNzWjsvgFNGdc-F9sJKKkeylXxkYAS3i6LgKXVy8JZYP1oiuO5Ha6UT3I-M9Sfo0yE3LUVUMaE6szMpRmeqgmGUvZAL9PkA7XP601ypag7FuGnS0aVWFAgqueCDGBZ0fUBNTqVk59U-h1nnRwVEPY2glhEWwdRhhMXw8Tm7bWdn_-MvX-__AcIvgjY</recordid><startdate>20151201</startdate><enddate>20151201</enddate><creator>Stein, Adam J</creator><creator>Bain, Gretchen</creator><creator>Prodanovich, Pat</creator><creator>Santini, Angelina M</creator><creator>Darlington, Janice</creator><creator>Stelzer, Nina M P</creator><creator>Sidhu, Ranjinder S</creator><creator>Schaub, Jeffrey</creator><creator>Goulet, Lance</creator><creator>Lonergan, Dave</creator><creator>Calderon, Imelda</creator><creator>Evans, Jilly F</creator><creator>Hutchinson, John H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>20151201</creationdate><title>Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding</title><author>Stein, Adam J ; Bain, Gretchen ; Prodanovich, Pat ; Santini, Angelina M ; Darlington, Janice ; Stelzer, Nina M P ; Sidhu, Ranjinder S ; Schaub, Jeffrey ; Goulet, Lance ; Lonergan, Dave ; Calderon, Imelda ; Evans, Jilly F ; Hutchinson, John H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-f716252a367af7d82890b86951c76db8621f22e84fd0df9d076a39dd8e76f9553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Cell Line, Tumor</topic><topic>Crystallization</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - metabolism</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>Mice</topic><topic>Phosphoric Diester Hydrolases - chemistry</topic><topic>Phosphoric Diester Hydrolases - metabolism</topic><topic>Protein Binding - physiology</topic><topic>Protein Structure, Secondary</topic><topic>Protein Structure, Tertiary</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stein, Adam J</creatorcontrib><creatorcontrib>Bain, Gretchen</creatorcontrib><creatorcontrib>Prodanovich, Pat</creatorcontrib><creatorcontrib>Santini, Angelina M</creatorcontrib><creatorcontrib>Darlington, Janice</creatorcontrib><creatorcontrib>Stelzer, Nina M P</creatorcontrib><creatorcontrib>Sidhu, Ranjinder S</creatorcontrib><creatorcontrib>Schaub, Jeffrey</creatorcontrib><creatorcontrib>Goulet, Lance</creatorcontrib><creatorcontrib>Lonergan, Dave</creatorcontrib><creatorcontrib>Calderon, Imelda</creatorcontrib><creatorcontrib>Evans, Jilly F</creatorcontrib><creatorcontrib>Hutchinson, John H</creatorcontrib><creatorcontrib>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stein, Adam J</au><au>Bain, Gretchen</au><au>Prodanovich, Pat</au><au>Santini, Angelina M</au><au>Darlington, Janice</au><au>Stelzer, Nina M P</au><au>Sidhu, Ranjinder S</au><au>Schaub, Jeffrey</au><au>Goulet, Lance</au><au>Lonergan, Dave</au><au>Calderon, Imelda</au><au>Evans, Jilly F</au><au>Hutchinson, John H</au><aucorp>Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2015-12-01</date><risdate>2015</risdate><volume>88</volume><issue>6</issue><spage>982</spage><epage>992</epage><pages>982-992</pages><issn>0026-895X</issn><issn>1521-0111</issn><eissn>1521-0111</eissn><abstract>Autotaxin (ATX) is a secreted enzyme that hydrolyzes lysophosphatidylcholine to lysophosphatidic acid (LPA). LPA is a bioactive phospholipid that regulates diverse biological processes, including cell proliferation, migration, and survival/apoptosis, through the activation of a family of G protein-coupled receptors. The ATX-LPA pathway has been implicated in many pathologic conditions, including cancer, fibrosis, inflammation, cholestatic pruritus, and pain. Therefore, ATX inhibitors represent an attractive strategy for the development of therapeutics to treat a variety of diseases. Mouse and rat ATX have been crystallized previously with LPA or small-molecule inhibitors bound. Here, we present the crystal structures of human ATX in complex with four previously unpublished, structurally distinct ATX inhibitors. We demonstrate that the mechanism of inhibition of each compound reflects its unique interactions with human ATX. Our studies may provide a basis for the rational design of novel ATX inhibitors.</abstract><cop>United States</cop><pmid>26371182</pmid><doi>10.1124/mol.115.100404</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2015-12, Vol.88 (6), p.982-992
issn 0026-895X
1521-0111
1521-0111
language eng
recordid cdi_osti_scitechconnect_1498378
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Animals
Cell Line, Tumor
Crystallization
Enzyme Inhibitors - chemistry
Enzyme Inhibitors - metabolism
HEK293 Cells
Humans
Mice
Phosphoric Diester Hydrolases - chemistry
Phosphoric Diester Hydrolases - metabolism
Protein Binding - physiology
Protein Structure, Secondary
Protein Structure, Tertiary
Structure-Activity Relationship
title Structural Basis for Inhibition of Human Autotaxin by Four Potent Compounds with Distinct Modes of Binding
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-03T07%3A07%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structural%20Basis%20for%20Inhibition%20of%20Human%20Autotaxin%20by%20Four%20Potent%20Compounds%20with%20Distinct%20Modes%20of%20Binding&rft.jtitle=Molecular%20pharmacology&rft.au=Stein,%20Adam%20J&rft.aucorp=Argonne%20National%20Lab.%20(ANL),%20Argonne,%20IL%20(United%20States).%20Advanced%20Photon%20Source%20(APS)&rft.date=2015-12-01&rft.volume=88&rft.issue=6&rft.spage=982&rft.epage=992&rft.pages=982-992&rft.issn=0026-895X&rft.eissn=1521-0111&rft_id=info:doi/10.1124/mol.115.100404&rft_dat=%3Cproquest_osti_%3E1728676474%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1728676474&rft_id=info:pmid/26371182&rfr_iscdi=true